Skip to main content
TipRanks
Go Ultimate75% OFF

Promisia Healthcare Limited (PHL) AI Stock Analysis

NZ:PHL

Promisia Healthcare Limited

(NZX:PHL)

Select Model
Rating:63Neutral
Price Target:NZD 0.67â–²(8.23% Upside)
Action:initiatedcoverage
Date:10/05/26

The score is supported primarily by improved financial performance (strong FY2026 profitability and reduced leverage) and a very low P/E valuation. These positives are tempered by mixed cash-flow reliability and weak technical signals (price below key moving averages with negative MACD and low RSI/stochastic).

Positive Factors
Profitability and revenue growthThe combination of meaningful revenue growth and a sharp increase in net margin indicates stronger earnings capacity entering the next several months. If profitability remains near FY2026 levels, Promisia can generate more internal resources to support operations, investment, and balance-sheet improvement.
Negative Factors
Inconsistent cash generationAlthough FY2026 cash flow improved, the history of negative free cash flow shows that earnings have not consistently translated into cash. Uneven conversion can constrain internally funded investment, create greater reliance on financing, and make future cash-based shareholder returns less predictable.

Promisia Healthcare Limited (PHL) vs. SPDR S&P 500 ETF (SPY)

-20%-10%0%10%20%30%40%50%NZ:PHL+12.73%SPY+4.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
NZD 34.16M
Dividend Yield
―
Average Volume (3M)
44.84K
Price to Earnings (P/E)
0.0
Beta (1Y)
0.93
Revenue Growth
15.19%
EPS Growth
1154.17%
Country
NZ
Employees
467
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Promisia Healthcare Limited Business Overview & Revenue Model

Company Description

Promisia Healthcare Limited engages in the aged care and retirement living business in New Zealand. It offers a range of living options, such as rest home, dementia, respite, young disabled, palliative, and hospital care, as well as independent livin...

Promisia Healthcare Limited Financial Statement Overview

Summary

Strong FY2026 profitability and revenue growth with a sharp improvement in net margin (~32%). Balance sheet leverage improved materially (debt-to-equity down to ~0.75), but the company has a recent history of high leverage and cash-flow consistency remains a key weakness (uneven cash conversion and prior negative free cash flow).

Income Statement

78Positive

Balance Sheet

62Positive

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2022
Income Statement
Total Revenue38.61M40.12M29.69M24.17M20.12M23.46M
Gross Profit23.61M37.86M29.69M24.17M20.12M23.46M
EBITDA4.86M6.41M9.99M7.06M5.20M3.50M
Net Income6.96M12.92M6.84M1.64M2.22M614.00K
Balance Sheet
Total Assets199.50M199.50M172.09M84.34M51.76M71.75M
Cash, Cash Equivalents and Short-Term Investments110.00K110.00K132.00K198.00K2.41M2.06M
Total Debt41.63M41.63M121.75M73.71M17.15M46.33M
Total Liabilities144.30M144.30M132.81M59.47M33.18M51.66M
Stockholders Equity55.20M55.20M39.27M28.66M18.58M20.09M
Cash Flow
Free Cash Flow5.10M5.83M3.12M7.17M2.75M-6.81M
Operating Cash Flow5.55M6.36M3.40M7.49M4.79M7.07M
Investing Cash Flow3.93M122.00K-10.56M-7.60M-2.04M-21.14M
Financing Cash Flow-10.38M-6.50M7.17M-1.83M-1.55M13.72M

Promisia Healthcare Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price0.62

Price Trends

50DMA0.66Negative
100DMA0.67Negative
200DMA0.59Positive

Market Momentum

MACD-0.01Positive
RSI37.57Neutral
STOCH0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:PHL, the sentiment is Negative. The current price of 0.62 is below the 20-day moving average (MA) of 0.65, below the 50-day MA of 0.66, and above the 200-day MA of 0.59, indicating a neutral trend. The MACD of -0.01 indicates Positive momentum. The RSI at 37.57 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NZ:PHL.

Promisia Healthcare Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

NZ:PHL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
NZ:SUMNZ:SUM66NeutralNZD 1.46B4.598.89%2.94%14.09%-18.30%
NZ:PHLNZ:PHL63NeutralNZD 33.62M0.03――15.19%1154.17%
NZ:TAHNZ:TAH58NeutralNZD 37.83M11.70―4.15%21.56%18.96%
NZ:RADNZ:RAD56NeutralNZD 113.39M10.18―6.03%9.76%-1.75%
NZ:RYMNZ:RYM56NeutralNZD 1.91B-11.12-4.17%―11.86%72.99%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
NZ:OCANZ:OCA50NeutralNZD 449.02M-63.44-0.57%―1.25%-117.68%

* Healthcare Sector Average

Performance Comparison

-40%-20%0%20%40%NZ:PHLNZ:OCANZ:RYMNZ:SUMNZ:TAHNZ:RADDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
NZ:PHL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
NZ:PHLPromisia Healthcare Limited0.620.0611.71%
NZ:OCAOceania Healthcare Ltd.0.59-0.22-27.16%
NZ:RYMRyman Healthcare 1.83-1.06-36.66%
NZ:SUMSummerset Group Holdings Limited5.79-6.60-53.27%
NZ:TAHThird Age Health Services Limited3.86-1.74-31.12%
NZ:RADRadius Residential Care Ltd0.400.024.99%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 05, 2026